WEB EXCLUSIVES
Factors Associated With Primary Hip Arthroplasty After Hip Fracture
Ishveen Chopra, MS; Khalid M. Kamal, PhD; Jayashri Sankaranarayanan, MPharm, PhD; and Gibbs Kanyongo, PhD
Patient, clinical, and hospital factors were associated with receiving primary hip arthroplasty versus no surgery after hip fracture in the United States.
2013 Volume 19 Number 3
Measuring Concurrent Oral Hypoglycemic and Antidepressant Adherence and Clinical Outcomes
Hillary R. Bogner, MD, MSCE; Heather F. de Vries, MSPH; Alison J. O’Donnell, BA; and Knashawn H. Morales, ScD
Self-reported adherence tended to overestimate medication adherence compared with electronic monitoring. Electronic monitoring of oral hypoglycemic agents but not self-reported adherence predicted glycemic control.
2013 Volume 19 Number 3
Spending and Mortality in US Acute Care Hospitals
John A. Romley, PhD; Anupam B. Jena, MD, PhD; June F. O’Leary, PhD; and Dana P. Goldman, PhD
Across the US, adults with major medical conditions were less likely to die in hospitals with higher spending levels, even after adjusting for patient risk.
2013 Volume 19 Number 2
The Cost of Implementing Inpatient Bar Code Medication Administration
Julie Ann Sakowski, PhD; and Alana Ketchel, MPP, MPH
Bar code medication administration can be an effective and potentially cost-saving solution to prevent harmful medication administration errors in the community hospital setting.
2013 Volume 19 Number 2
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder
Kenneth J. Smith, MD, MS; Seo Hyon Baik, PhD; Charles F. Reynolds III, MD; Bruce L. Rollman, MD, MPH; and Yuting Zhang, PhD
In Medicare Part D, generic drug coverage was cost saving compared with no coverage in bipolar disorder and schizophrenia while improving health outcomes.
2013 Volume 19 Number 2
Introducing Forensic Health Services Research
Laurence F. McMahon Jr, MD, MPH; and Vineet Chopra, MD, MSc
The use of health services research to uncover healthcare fraud and abuse represents a novel, yet timely, implementation of this science.
2013 Volume 19 Number 2
Guidance for Structuring Team-Based Incentives in Healthcare
Daniel M. Blumenthal, MD, MBA; Zirui Song, PhD; Anupam B. Jena, MD, PhD; and Timothy G. Ferris, MD, MPH
Team-based performance incentives may improve healthcare team performance, but provider organizations face a number of structural, technical, and cultural barriers to adopting them.
2013 Volume 19 Number 2
Statin Cost and Utilization Outcomes After Implementation of Reference-Based Pricing
Cheryl J. Kaye, PharmD; Dwight A. Davis, PharmD; Kathryn K. Neill, PharmD; and Jill T. Johnson, PharmD
Reference-based pricing of statins decreased plan costs and beneficiary costs for a managed care plan and was associated with an increased utilization of statins.
2013 Volume 5 Number 1
Adherence to 5-ASA Therapy in Ulcerative Colitis: Budget Impact Analysis
Linnette Yen,† MS, MA; Tara K. Knight, PhD; Gunjan Sharma, MBA; Michael B. Nichol, PhD; John D. McDermott, Jr, MBA; and Paul Hodgkins, PhD
In patients with ulcerative colitis, choice of 5-aminosalicylic acid medications by therapeutic value rather than cost may improve patient care and increase savings.
2013 Volume 5 Number 1
Medicare Part D and FEHBP: Drug Selection Guidance for Clinicians
Jill Augustine, PharmD, MPH; and Annesha Lovett, PhD, MS, PharmD
Medicare Part D and the Federal Employees Health Benefits Program drug plans provide wide coverage of the top 10 therapeutic classes of drugs.
2013 Volume 5 Number 1